Journal of Pediatric Hematology/Oncology Nursing

This Journal is a member of the Committee on Publication Ethics

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/jophon to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

As of January 1, 2022, Journal of Pediatric Oncology Nursing changed its name to Journal of Pediatric Hematology/Oncology Nursing.

Sage Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.

Only manuscripts of sufficient quality that meet the aims and scope of Journal of Pediatric Hematology/Oncology Nursing will be reviewed.

If desired, authors are able to publish their article Open Access. For more information on open access options, fees, and compliance at Sage, including self-author archiving deposits (green open access) visit Sage Publishing Policies on our Journal Author Gateway.

As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that JOPHON will consider submissions of papers that have been posted on preprint servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper to a preprint server while it is being peer reviewed for possible publication in the Journal. If your paper is accepted, you will need to contact the preprint server to ensure the final published article link is attached to your preprint. Learn more about our preprint policy here.

What do we publish?

Aims & Scope

Before submitting your manuscript to Journal of Pediatric Hematology/Oncology Nursing, please ensure you have read the Aims & Scope. Content must be pertinent to the specialty of pediatric hematology/oncology nursing.

Article types

The Editorial Board welcomes submission of manuscripts for review for publication in the Journal of Pediatric Hematology/Oncology Nursing. Categories of manuscript types are listed below under manuscript preparation.  Query letters are also welcomed and should be sent to the editor: Kristin Stegenga kstegenga@cmh.edu. All manuscripts should be submitted online through Manuscript Central: http://mc.manuscriptcentral.com/jophon where authors will be required to set up an online account on the SageTrack system powered by ScholarOne.

Writing your paper

The Sage Author Gateway has some general advice and on how to get published, plus links to further resources.

Manuscript Preparation

To avoid delays in the review process, manuscripts should be carefully prepared according to these guidelines and proofread thoroughly for errors in grammar and spelling. The manuscript should be read for clarity and accuracy by colleagues and/or mentors before submission to the Journal of Pediatric Hematology/Oncology Nursing. 

Authors are invited to submit manuscripts in the following categories and formats described below.  The relevant EQUATOR Network  reporting guidelines should be followed depending on the type of manuscript.  The EQUATOR wizard can help you identify the appropriate guideline. Specific guidelines applicable to each type of manuscript at also noted below in the category descriptions.

Sage does not directly deposit all content to PMC, only NIH funded research. Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

For example: For quality improvement papers, the EQUATOR wizard can help you identify the appropriate guideline to follow.

Manuscript Categories

• Research. The report of an original investigation. Sections in the body of the manuscript include Introduction, Methods, Results, Discussion (including implications for future research and/or clinical practice), and references. If applicable, figures (with legends) and tables should be provided. Manuscripts describing investigations carried out in humans or animals must include a statement indicating that the study was approved by the authors’ institutional review committee and if written permission was required, it was obtained from human subjects.

All randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Qualitative research should follow the SRQR guidelines with studies using interviews or focus groups following the COREQ guidelines.

• Critical Review. A collation, description, and critically evaluation of previously published material to aid in evaluating new concepts. This includes Scoping Review, Integrative review, Systematic Review, Meta-synthesis and Meta-analysis.  Sections of the manuscript body includes Introduction, Methods, Results, Discussion and Summary, and references. Tables should be provided and if applicable, figures (with legends) should be included as well.

Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with the submission as a supplementary file.

• Quality Improvement – A report of a systematic change to apply evidence to address a clinical problem.  In the body of the manuscript, the sections included are Introduction, Methods, Results, Discussion, including implications clinical practice), and references. If applicable, figures (with legends) and tables should be provided. Manuscripts should indicate whether approval by institutional review board was required and if so, was obtained. SQUIRE 2.0 guidelines should be applied.

• Case Report – A report of an individual case or case series that demonstrates novel findings, contributes to current knowledge, or adds exceptional educational value. The authors must have been personally associated with the case. Sections of the manuscript body include the Case Summary, and Discussion to a maximum of 4 pages), and references. If applicable, figures (with legends) and tables should be provided.  The CARE checklist should be used to guide content.

• Process - An innovative and rigorous description of a topic of concern to pediatric hematology/oncology nursing. Examples might include the process of developing a new and novel program to meet the needs of patients, families or clinicians or a report that incorporates ethical principles applied rigorously to a case of interest.  Other ideas might include the report of a research method adapted in a novel way to better meet the needs of pediatric hematology/oncology patients or clinicians or a report on the use of a biomarker or other measure that has not previously been used in pediatric hematology/oncology or in the way you have adapted it. The manuscript should demonstrate innovation, new knowledge and rigor and should advance the art and science of pediatric hematology/oncology nursing. Sections in the body of the manuscript include Introduction, Description of Process or Innovation, Result (as appropriate), Discussion, Implications for Pediatric Hematology/Oncology Nursing and references. Page count and references should follow the same instructions as other papers except case studies.

Note to Students: Students are held to the same rigor and standards as other authors. Student papers must be formatted and submitted following the author guidelines for the Journal of Pediatric Hematology/Oncology Nursing. We encourage collaboration with faculty mentors to ensure that the paper is in publishable form prior to submission.

NOTE: Your document should be exported from your reference manager. Please note that reference management systems do not always format references correctly so please double check reference formatting prior to submission.

Required Format

Manuscripts should be set in 12-point font type, 1-inch margins, and not exceed 20 double-spaced pages (with the exception of Case Report which is 4 pages), excluding references, figures, and tables. Number the pages from the first page of the text to the end of the references.

The second page should include a 250-word or less structured abstract (see detailed instructions below)

• Title Page – Submitted as a separate file. Title page should include the following information: (1) title of the paper, (2) author name(s), degree(s), and current position, (3) complete addresses (including email address) for every author, (4) name and address of the author to whom communications should be addressed. Please ensure that the corresponding author matches what is submitted in the ScholarOne system and that all authors are also entered into ScholarOne.

• Keywords – Provide 3 to 5 keywords or phrases for indexing purposes. Choose keywords from the drop-down options when submitting your manuscript.

• Structured Abstract – The abstract (maximum of 250 words) will appear as the italicized lead-in portion of the published manuscript and must include the following headings: Background, Methods, Results, and Discussion. The abstract of the article should include 1 to 3 sentences describing the purpose, hypothesis, or theoretical orientation of the article (Background), followed by 2 to 3 sentences describing the method of the study or the nature of the review (Methods). For a research article, include how the data were analyzed. Continue with 2 to 3 sentences devoted to the major points or results noted in the article (Results), and conclude with 1 to 2 sentences giving the conclusion or take-home message (Discussion). Please ensure the abstract is also uploaded as a separate file in the submission process.

Illustrations and Tables

The use of figures is encouraged. Original glossy photographs or electronic image files (TIF, JPG or EPS for-mats), preferably in black and white, must be supplied with the manuscript (photocopies cannot be used for reproduction). Files should be in TIF, JPG, or EPS format and line art images should be saved at 1200 dpi, and grayscale images should be saved at 300 dpi. Tables and figures should be presented in separate, individual electronic files and not incorporated into the Main Manuscript Document.

Use of a human being’s photograph requires written consent from the individual. Release forms can be obtained by contacting the Editor, Kristin Stegenga.

Tables should be formatted following the Publication Manual of American Psychological Association (APA), 7th edition.

A legend should be provided for each figure in APA format, 7^th edition. A legend must accompany each illustration. Contributors must bear the cost of reproducing color illustrations.

Figures and tables should be cited in order in the text using Arabic numerals. The author must provide permission to reprint figures and tables from other sources. Standard copyright permission forms are available from the Editor.

References

References follow the style used by the Publication Manual of American Psychological Association (APA), 7th edition.  Resources are available at http://www.apastyle.org  References should be cited in text with an author-date citation system and are listed alphabetically in the Reference section in APA style. They should be typewritten and double-spaced, under the heading REFERENCES. Please also include the DOI number, if available.

JOPHON adheres to a rigorous double-anonymous policy for peer review of manuscripts in which the identity of both the reviewer and author are concealed from both parties. The citations in which you or any co-authors appear as well as the corresponding references should be anonymized. In text citations should read (Anonymous, Year) and then in the corresponding reference, cite (Anonymous, year) in place of the reference.

Please watch this YouTube video on what has changed with the 7^th edition: https://blog.apastyle.org/apastyle/announcements/ 

Examples of References

Journal articles 
Duffy, E. A., Rodgers, C. C., Shever, L. L., & Hockenberry, M. J. (2015). Implementing a daily maintenance care bundle to prevent central line-associated bloodstream infections in pediatric oncology patients. Journal of Pediatric Oncology Nursing, 32(6), 394 – 400. http://doi.org/10.1177/1043454214563756

Mandrell, B. N., Baker, J., Levine, D., Gattuso, J., West, N., Sykes, Gajjar, A., & Broniscer, A. (2016). Journal of Neuro-Oncology, 129(2), 373-381. http://doi.org/10.1007/s11060-016-2187-9

Complete book
Zaccagnini, M. E. & White, K. W. (2017). The Doctor of Nursing Practice Essentials (3rd ed.). Jones & Bartlett Learning.

Chapter of a book
Hendershot, E. (2011). Retinoblastoma. In C. Baggott, G. V. Foley, D. Fochtman, & K. P. Kelly (Eds), Nursing care of children and adolescents with cancer and blood disorders (4th ed., pp. 1106-1120). Association of Pediatric Hematology/Oncology Nurses.

Website
Children’s Oncology Group. (2018). Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers (Version 5). http://survivorshipguidelines.org/

Proofreading

Contributors are provided with printed proofs and are asked to proofread them for typesetting errors. Important changes in data are allowed, but authors will be charged for excessive alterations. Proofs should be returned to the publisher within the due date given.

ONCC Certification Listings

The Oncology Nursing Certification Corporation owns the OCN, CPHON, CBCN, BMTCN AOCNP, AOCNS, CPON, and AOCN credentials. Please use the registered trademark symbol ® when listing credentials in reference to or within an individual's credentials listing.

Make your article discoverable

For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online

Editorial policies

Peer review policy

JOPHON operates a conventional double-anonymous reviewing policy in which the reviewer’s name is always concealed from the submitting author and the author(s)’ name is not known by the reviewer.

Publons

Journal of Pediatric Hematology/Oncology Nursing is committed to delivering high quality, fast peer-review for your paper, and as such has partnered with Publons. Publons is a third party service that seeks to track, verify and give credit for peer review. Reviewers for JOPHON can opt in to Publons in order to claim their reviews or have them automatically verified and added to their reviewer profile. Reviewers claiming credit for their review will be associated with the relevant journal, but the article name, reviewer’s decision and the content of their review is not published on the site. For more information visit the Publons website.

The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor/Board member will have no involvement in the decision-making process.

Authorship

Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors. The list of authors should include all those who can legitimately claim authorship. This is all those who:

(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

Authors should meet the conditions of all of the points above. When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

Please note that AI chatbots, for example ChatGPT, should not be listed as authors. For more information see the policy on Use of ChatGPT and generative AI tools.

Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

Third party submissions

Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:

• Disclose this type of editorial assistance – including the individual’s name, company and level of input
• Identify any entities that paid for this assistance
• Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.

Where appropriate, Sage reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.

Writing assistance

Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance”).

It is not necessary to disclose use of language polishing services.

Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

Artificial Intelligence

Use of Large Language Models and generative AI tools in writing your submission

Sage recognizes the value of large language models (LLMs) (e.g. ChatGPT) and generative AI as productivity tools that can help authors in preparing their article for submission; to generate initial ideas for a structure, for example, or when summarizing, paraphrasing, language polishing etc. However, it is important to note that all language models have limitations and are unable to replicate human creative and critical thinking. Human intervention with these tools is essential to ensure that content presented is accurate and appropriate to the reader. Sage therefore requires authors to be aware of the limitations of language models and to consider these in any use of LLMs in their submissions:

• Objectivity: Previously published content that contains racist, sexist or other biases can be present in LLM-generated text, and minority viewpoints may not be represented. Use of LLMs has the potential to perpetuate these biases because the information is decontextualized and harder to detect.
• Accuracy: LLMs can ‘hallucinate’ i.e. generate false content, especially when used outside of their domain or when dealing with complex or ambiguous topics. They can generate content that is linguistically but not scientifically plausible, they can get facts wrong, and they have been shown to generate citations that don’t exist. Some LLMs are only trained on content published before a particular date and therefore present an incomplete picture.
• Contextual understanding: LLMs cannot apply human understanding to the context of a piece of text, especially when dealing with idiomatic expressions, sarcasm, humor, or metaphorical language. This can lead to errors or misinterpretations in the generated content.
• Training data: LLMs require a large amount of high-quality training data to achieve optimal performance. However, in some domains or languages, such data may not be readily available, limiting the usefulness of the model.

Guidance for authors

Authors are required to:

1. Clearly indicate the use of language models in the manuscript, including which model was used and for what purpose. Please use the methods or acknowledgements section, as appropriate.
2. Verify the accuracy, validity, and appropriateness of the content and any citations generated by language models and correct any errors or inconsistencies.
3. Provide a list of sources used to generate content and citations, including those generated by language models. Double-check citations to ensure they are accurate, and are properly referenced.
4. Be conscious of the potential for plagiarism where the LLM may have reproduced substantial text from other sources. Check the original sources to be sure you are not plagiarizing someone else’s work.
5. Acknowledge the limitations of language models in the manuscript, including the potential for bias, errors, and gaps in knowledge.
6. Please note that AI bots such as ChatGPT should not be listed as an author on your submission.

We will take appropriate corrective action where we identify published articles with undisclosed use of such tools.

Funding 

Journal of Pediatric Hematology/Oncology Nursing requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the Sage Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Declaration of conflicting interests

It is the policy of Journal of Pediatric Hematology/Oncology Nursing to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles. Authors must disclose commercial associations that might pose a conflict of interest in connection with submitted work. Such associations include consultancies, speaking on behalf of a vendor, equity interests, or patent licensing arrangements.

Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

For guidance on conflict of interest statements, please see the ICMJE recommendations here

Research ethics and patient consent

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants

All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.

Clinical trials

Journal of Pediatric Hematology/Oncology Nursing endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract

Data

Sage acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

Journal of Pediatric Hematology/Oncology Nursing requests all authors submitting any primary data used in their research articles [“alongside their article submissions” or “if the articles are accepted”] to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. [The editor(s) may consider limited embargoes on proprietary data.] The editor(s) [can/will] also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations.

Transparency is important; please always note where you data is coming from. Following COPE standards, “researchers should strive to describe their methods and to present their findings clearly and unambiguously. Researchers should follow applicable reporting guidelines. Publications should provide sufficient detail to permit experiments to be repeated by other researchers.” Also, “the appropriate statistical analyses should be determined at the start of the study and a data analysis plan for the pre-specified outcomes should be prepared and followed. Secondary or post hoc analyses should be distinguished from primary analyses and those set out in the data analysis plan.”

For further information, please contact the editorial office at kstegenga@cmh.edu

Publishing Policies

Publication ethics

Sage is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the Sage Author Gateway

Plagiarism

Journal of Pediatric Hematology/Oncology Nursing and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

Prior publication

If material has been previously published it is not generally acceptable for publication in a Sage journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the Sage Author Gateway or if in doubt, contact the Editor at the address given below.

Contributor’s publishing agreement

Before publication, Sage requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Sage’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants Sage the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than Sage. In this case copyright in the work will be assigned from the author to the society. For more information please visit the Sage Author Gateway

There are no fees payable to submit or publish in this Journal. Open Access options are available — see below

Open access and author archiving

Journal of Pediatric Hematology/Oncology Nursing offers optional open access publishing via the Sage Choice programme and Open Access agreements, where authors can publish open access either discounted or free of charge depending on the agreement with Sage. Find out if your institution is participating by visiting Open Access Agreements at Sage. For more information on Open Access publishing options at Sage please visit Sage Open Access. For information on funding body compliance, and depositing your article in repositories, please visit Sage’s Author Archiving and Re-Use Guidelines and Publishing Policies.

Identifiable information 

Authors are required to submit: 

1. A version of the manuscript which has had any information that compromises the anonymity of the author(s) removed or anonymized. This version will be sent to the peer reviewers. 
2. A separate title page which includes any removed or anonymized material. This will not be sent to the peer reviewers. 

See https://sagepub.com/Manuscript-preparation-for-double-blind-journal for detailed guidance on making an anonymous submission.

Supplementary material

This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files

English language editing services

Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using Sage Language Services. Visit Sage Language Services on our Journal Author Gateway for further information. Please consider engaging this service prior to submission.

Submitting your manuscript

JOPHON is hosted on Sage Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/jophon to login and submit your article online.

IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Help.

ORCID

As part of our commitment to ensuring an ethical, transparent and fair peer review process Sage is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.

The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.

If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage to learn more

Information required for completing your submission

You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

Permissions

Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the Sage Author Gateway

On acceptance and publication

Sage Production

Your Sage Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate.

Online First publication

Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the Sage Journals help page for more details, including how to cite Online First articles.

Access to your published article

Sage provides authors with online access to their final article.

Promoting your article

Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The Sage Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.

Further information

Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Journal of Pediatric Hematology/Oncology Nursing editorial office as follows:

Kristin Stegenga, PhD, RN
Email: kstegenga@cmh.edu

Appealing the publication decision

Editors have very broad discretion in determining whether an article is an appropriate fit for their journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for formal appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article, in which case the author may appeal the decision by providing the Editor with a detailed written description of the error they believe occurred.

If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author may contact the publisher with a detailed written description of their concern, and information supporting the concern, at publication_ethics@sagepub.com.